Original language | English (US) |
---|---|
Pages (from-to) | 243-251 |
Number of pages | 9 |
Journal | Journal of Pediatrics |
Volume | 199 |
DOIs |
|
State | Published - Aug 2018 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome. / Gilbert, Donald L.; Mink, Jonathan W.; Singer, Harvey S.
In: Journal of Pediatrics, Vol. 199, 08.2018, p. 243-251.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome
AU - Gilbert, Donald L.
AU - Mink, Jonathan W.
AU - Singer, Harvey S.
N1 - Funding Information: D.G. received honoraria and/or travel support from the Tourette Association of America/ Centers for Disease Control and Prevention, the American Academy of Pediatrics, and the Child Neurology Society, compensation for expert testimony for the US National Vaccine Injury Compensation Program, through the Department of Health and Human Services, research support from the National Institutes of Health (NIH) (National Institute of Mental Health, National Institute of Neurological Disorders and Stroke), funding for work as a clinical trial site investigator from Psyadon Pharmaceuticals (clinical trial, Tourette Syndrome) and EryDel (clinical trial, Ataxia Telangiectasia), book royalties from Elsevier and Wolters Kluwer. J.M. received honoraria from the American Academy of Neurology as Associate Editor of Neurology, grant support from NIH, Centers for Disease Control and Prevention, Beyond Batten Disease Foundation, Batten Research Alliance, Noah's Hope, Batten Disease Support and Research Association, and Abeona Inc, compensation for expert testimony for the US National Vaccine Injury Compensation Program, through the Department of Health and Human Services, served as a consultant to Abide Inc, Censa Inc, and Teva Inc, and has received book royalties from Elsevier and from John Wiley & Sons. H.S. received research support from the NIH and the Tourette Association of America, funding for work as a clinical trial site investigator from Ecopipam Pharmaceuticals, served as a consultant for Teva Brand Pharmaceutical Products Research and Development, and received book royalties from Elsevier. The authors declare no conflicts of interest.
PY - 2018/8
Y1 - 2018/8
UR - http://www.scopus.com/inward/record.url?scp=85047181320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047181320&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2018.04.035
DO - 10.1016/j.jpeds.2018.04.035
M3 - Comment/debate
C2 - 29793872
AN - SCOPUS:85047181320
SN - 0022-3476
VL - 199
SP - 243
EP - 251
JO - Journal of Pediatrics
JF - Journal of Pediatrics
ER -